Vaginal Contraceptive Drug Products for Over-the-Counter Human Use; Reopening of the Administrative Record

Resumo

The Food and Drug Administration (FDA) is announcing the reopening of the administrative record for the proposed rulemaking for over-the-counter (OTC) vaginal contraceptive drug products to allow for comment on matters considered at the November 22, 1996, joint meeting of the Nonprescription Drugs, Reproductive Health Drugs, Anti-Infective Drugs, and Antiviral Drugs Advisory Committees. That meeting is part of the ongoing review of OTC drug products conducted by FDA.